Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial

Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial

Abstract Background Although topical steroids constitute the first-line therapy for recurrent aphthous ulcers (RAUs), their long-term use often leads to candidiasis. Although cannabidiol (CBD) can be an alternative for pharmacologically managing RAUs due to its analgesic and anti-inflammatory in viv...

Full description

Bibliographic Details
Main Authors: Chalapinyo Umpreecha, Kanokporn Bhalang, Dusadee Charnvanich, Jittima Luckanagul
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Cannabidiol
CBD
Cannabis
Cannabinoids
Recurrent aphthous ulcer
Recurrent aphthous stomatitis
Online Access:https://doi.org/10.1186/s12906-023-03886-0

Internet

https://doi.org/10.1186/s12906-023-03886-0

Similar Items